IL15, interleukin 15, 3600

N. diseases: 426; N. variants: 10
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Carcinoma of urinary bladder, invasive
0.020 Biomarker disease BEFREE Together, an immunosuppressive tumor environment in nonmuscle invasive bladder cancer that have failed prior BCG may respond better to interleukin-15 immunotherapy compared with tumors without an immunosuppressive environment. 31107371 2019
Carcinoma of urinary bladder, invasive
0.020 Biomarker disease BEFREE BCG-IL-15 may be a promising drug for non-muscle invasive bladder cancer. 27093372 2016